Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

NCT03595553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

759

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridioides Difficile Infection

Interventions

DRUG: Ridinilazole
DRUG: Vancomycin

Sponsor

Summit Therapeutics